FORADILE

I appreciate the detailed instructions, but

I need to inform you that the provided source documents do not contain sufficient information to create a comprehensive Brand Dossier for FORADILE.

The documents provided are:

1. **Document 1**: Product information for SEEBRI BREEZHALER (glycopyrronium), a different medicine entirely. 2. **Document 2**: Minimal ARTG registration data for FORADILE (formoterol fumarate 12 microgram), showing only the registration number and first listing date. 3. **Document 3**: Basic PBS listing information for FORADILE showing strength, item count, restriction type, and ex-manufacturer price.

To create a proper Brand Dossier for FORADILE according to your specifications, I would need source documents containing: — Clinical indication details (approved indications beyond the generic respiratory category) — Detailed dosing information for different indications — Key safety warnings and contraindications specific to formoterol fumarate — Regulatory history including PBAC outcomes and dates — ARTG registration date and any updates — Whether it carries a Black Triangle status — An AusPAR if available

**I recommend providing the FORADILE Product Information document and any regulatory correspondence** (such as PBAC advice, TGA correspondence, or AusPAR) to enable me to produce the dossier with proper citations to authoritative sources.